Literature DB >> 21878737

Intensified expressions of a monocarboxylate transporter in consistently renewing tissues of the mouse.

Kumiko Takebe1, Hiromi Takahashi-Iwanaga, Toshihiko Iwanaga.   

Abstract

Monocarboxylates-lactate and ketone bodies-can compensate for glucose as energy sources under certain physical conditions. To identify the main energy source used in self-renewing tissues, expression profiles of monocarboxylate transporters (MCTs) were mainly investigated immunohistochemically in the gastrointestinal tract, skin, and bone marrow of mice, with reference to glucose transporters. In the small intestine, MCT1-immunoreactive epithelial cells accumulated in crypts with a selective immunolabeling along the basolateral membrane of cells. BrdU-labeled dividing cells were included in the cryptal MCT1-immunoreactive foci. The skin displayed an intense and extensive immunoreactivity for MCT1 in the hair bulge, which gives rise to the epidermis, hair, and sebaceous gland. The stratified squamous epithelium in the esophagus contained MCT1-immunoreactive cells in the basal layer but frequently lacked GLUT1-immunoreactive cells. The bone marrow was largely immunoreactive for MCT1 but not for GLUT1, suggesting the active production and utilization of monocarboxylates for hematopoiesis under hypoxic conditions. These findings support the idea that monocarboxylates are favorite energy sources in self-renewing tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878737     DOI: 10.2220/biomedres.32.293

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  3 in total

1.  Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.

Authors:  Patrizia Sanità; Mattia Capulli; Anna Teti; Giuseppe Paradiso Galatioto; Carlo Vicentini; Paola Chiarugi; Mauro Bologna; Adriano Angelucci
Journal:  BMC Cancer       Date:  2014-03-05       Impact factor: 4.430

2.  Monocarboxylate transporter-1 promotes osteoblast differentiation via suppression of p53, a negative regulator of osteoblast differentiation.

Authors:  Kiyohito Sasa; Kentaro Yoshimura; Atsushi Yamada; Dai Suzuki; Yoichi Miyamoto; Hiroko Imai; Kazuhiro Nagayama; Koutaro Maki; Matsuo Yamamoto; Ryutaro Kamijo
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

3.  Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance.

Authors:  Izumi Kaji; Joseph T Roland; Sudiksha Rathan-Kumar; Amy C Engevik; Andreanna Burman; Anna E Goldstein; Masahiko Watanabe; James R Goldenring
Journal:  JCI Insight       Date:  2021-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.